Dr. Furlan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1100 Olive Way
Ste 100
Seattle, WA 98101Phone+1 206-884-4053
Summary
- Dr. Scott Furlan is a pediatric hematologist/oncologist at the Fred Hutchinson Cancer Center in Seattle, WA and is affiliated with Seattle Children's Hospital. He received his medical degree from University of Southern California School of Medicine and has been in practice 15 years. He is experienced in transplant immunology, tumor immunology, adoptive immunotherapy, omics, and regulatory t-lymphocytes. He has more than 20 publications and over 500 citings.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2009 - 2012- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2006 - 2009
Keck School of Medicine of the University of Southern CaliforniaClass of 2006
Certifications & Licensure
CA State Medical License 2012 - Present
WA State Medical License 2013 - 2026
TX State Medical License 2008 - 2013
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 6 citationsHA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.Elizabeth F Krakow, Michelle Brault, Corinne Summers, Tanya M Cunningham, Melinda A Biernacki
Blood. 2024-09-05 - 2 citationsMicrobiota dictate T cell clonal selection to augment graft-versus-host disease after stem cell transplantation.Albert C Yeh, Motoko Koyama, Olivia G Waltner, Simone A Minnie, Julie R Boiko
Immunity. 2024-07-09 - 3 citationsCalcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD.Yewei Wang, Md Ashik Ullah, Olivia G Waltner, Shruti S Bhise, Kathleen S Ensbey
The Journal of Clinical Investigation. 2024-06-03
Lectures
- IL2 and Rapamycin Enhance Persistence of Adoptively-Transferred Ex-Vivo Expanded T Regulatory Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Pharmacologic Blockade of Notch/Delta-like Ligand 4 Signaling Protects from Gastrointestinal Acute Graft-Versus-Host Disease in Non-Human Primates2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- BBI Funds ‘Entirely Novel Approach’ to Studying Pediatric LeukemiaFebruary 28th, 2022
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
